| Dr. James Young |
Independent Chairman of the Board |
70 |
$561.6K - USD |
Male |
|
| Mr. John Jacobs |
President, Chief Executive Officer, Director |
56 |
- |
Male |
|
| Mr. John Trizzino |
President, Chief Operating Officer |
63 |
$3.078M - USD |
Male |
|
| Mr. James Kelly |
Chief Financial Officer, Executive Vice President, Treasurer |
57 |
$3.081M - USD |
Male |
|
| Mr. Filip Dubovsky |
President, Research and Development |
58 |
- |
Male |
|
| Mr. John Herrmann |
Executive Vice President |
57 |
$3.095M - USD |
Male |
|
| Ms. Elaine O'hara |
Executive Vice President, Chief Strategy Officer |
55 |
- |
Female |
|
| Mr. Gale Smith |
Senior Vice President - Discovery and Pre-Clinical Research, Chief Scientist |
|
- |
Male |
|
| Mr. Mark Casey |
Chief Legal Officer and Corporate Secretary |
59 |
- |
Male |
|
| Mr. Gregg Alton |
Independent Director |
57 |
$378.1K - USD |
Male |
|
| Dr. Richard Douglas |
Independent Director |
70 |
$382.6K - USD |
Male |
|
| Ms. Rachel King |
Independent Director |
63 |
$368.5K - USD |
Female |
|
| Ms. Margaret Mcglynn |
Independent Director |
63 |
$369.2K - USD |
Female |
|
| Mr. David Mott |
Independent Director |
57 |
$380.6K - USD |
Male |
|
| Mr. Richard Rodgers |
Independent Director |
56 |
$639.5K - USD |
Male |
|
